3 Biotech Stocks That Could Rise 90% or More, According to Wall Street

3 Biotech Stocks That Could Rise 90% or More, According to Wall Street

Source: 
Motley Fool
snippet: 
  • ChemoCentryx recently produced compelling trial data that led Wall Street analysts who follow the biotech to raise their price targets.
  • Ocular Therapeutix is a commercial-stage drugmaker that just earned a label expanding approval for its sole product, Dextenza.
  • Axsome Therapeutics is a clinical-stage company with two new drug applications under review at the FDA.